Bill
Bill > S09172
NY S09172
NY S09172Provides that clinical laboratories may provide laboratory testing at the request of individuals, without a practitioner order or prescription, for certain types of cholesterol.
summary
Introduced
02/10/2026
02/10/2026
In Committee
02/10/2026
02/10/2026
Crossed Over
Passed
Dead
Introduced Session
2025-2026 General Assembly
Bill Summary
AN ACT to amend the public health law, in relation to direct access laboratory testing for certain lipid screening assays
AI Summary
This bill allows licensed clinical laboratories in New York to perform certain cholesterol tests, specifically low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides, total cholesterol, and lipoprotein(a) (Lp(a)), directly for individuals without requiring a doctor's order or prescription. These tests are often referred to as "lipid screening assays" and are used to assess cardiovascular health. The bill mandates that laboratories provide test results in a clear format and adhere to all relevant state and federal regulations, including the Clinical Laboratory Improvement Amendments of 1988 (CLIA), which sets quality standards for laboratory testing. Importantly, this new provision does not permit laboratories to diagnose or treat conditions, nor does it expand the practice scope of any healthcare professional; it strictly limits direct access testing to the specified cholesterol-related assays.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
REFERRED TO HEALTH (on 02/10/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.nysenate.gov/legislation/bills/2025/S9172 |
| BillText | https://assembly.state.ny.us/leg/?default_fld=&bn=S09172&term=2025&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#S09172 |
Loading...